ESS Trial will likely start now that AMDX is off the books. Result will be true valuation for a therapeutics biz. Might hear about a partner on the ESS front too. Just my opinion based on the way things are shaking out here.
(7)
(1)
Amarantus Bioscience Holdings (AMBS) Stock Research Links
